New Trials of Antithrombotic Therapy for ACS -- ACC 2006 Christopher P. Cannon, MD
•
Latest Data on Treating Atrial Fibrillation -- From Ablation to Adjunctive Drugs Eric N. Prystowsky, MD
Interventional Corner
This year, the ACC introduced the Innovation in Intervention: i2 Summit 2006 -- the first meeting-within-a-meeting at the ACC specifically geared toward interventional cardiology. The Summit, which was cosponsored by the Society for Cardiovascular Angiography and Interventions (SCAI), provided a forum for experts to discuss the latest advances in this constantly evolving field. However, it was not only the i2 Summit that featured topics on interventional cardiology; research in this field was also a prominent focus during the main ACC Sessions. With our coverage of the ACC 2006 meeting and i2 Summit, Medscape Cardiology is inaugurating a special section -- Interventional Corner -- led by Luis Gruberg, MD, highlighting research and clinical advances in this all-important arena. Below are selected summaries with viewpoints from the late-breaking trial presentations on interventional cardiology held during both meetings.
Conference Review - Imaging in Intervention: Emerging Technologies As described in this session, advances in imaging technology will enable us to understand the pathologic changes and therefore provide a wider range of therapeutic alternatives to our patients.
TROPHY: Trial Of Preventing Hypertension JNC 7 redefined the JNC VI "high normal" BP category as "prehypertension" -- TROPHY asked what happens if prehypertensive BP levels are treated with drugs, and is this to be recommended?
The Pediatric Randomized Carvedilol Trial in Children with Heart Failure Carvedilol has a proven track record in adult heart failure (HF) patients and a presumed one in children -- but this first clinical trial in pediatric HF suggests that perhaps that presumption is not evidence-based.
The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the American College of Cardiology 55th Annual Scientific Session. These materials and the related activity are not sanctioned by the American College of Cardiology 55th Annual Scientific Session or the commercial supporter of the conference, and do not constitute an official part of that conference.
The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.
